Contact Information
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
PediatricsNeonatology700 Childrens DrColumbus, OH 43205 (map)
Learn more about Matthew J. Kielt
Biography
Matthew J, Kielt, MD, is an attending neonatologist at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Kielt’s clinical interests include bronchopulmonary dysplasia (BPD) and neonatal pulmonary vascular disease. He practices in the Comprehensive Center for Bronchopulmonary Dysplasia. Dr. Kielt’s research interests focus on improving outcomes of infants with the most severe forms of BPD through the development of precision medicine strategies of neonatal care.
Academic and Clinical Areas
Neonatology
Physician Team
Neonatology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Neonatology
Research
Publications
Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 May 16;
Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 07/01/2019
Board Certifications
Neonatal-Perinatal Medicine Pediatrics
Fellowship
Vanderbilt University Medical Center
Date Completed: 06/30/2019
Residency
University of Kansas School of Medicine
Date Completed: 06/30/2016
Medical School
University of Kansas
Date Completed: 05/18/2013
Contact Information
Pediatrics
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
PediatricsNeonatology700 Childrens DrColumbus, OH 43205 (map)
Learn more about Matthew J. Kielt
Biography
Matthew J, Kielt, MD, is an attending neonatologist at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Kielt’s clinical interests include bronchopulmonary dysplasia (BPD) and neonatal pulmonary vascular disease. He practices in the Comprehensive Center for Bronchopulmonary Dysplasia. Dr. Kielt’s research interests focus on improving outcomes of infants with the most severe forms of BPD through the development of precision medicine strategies of neonatal care.
Academic and Clinical Areas
Neonatology
Physician Team
Neonatology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Neonatology
Research
Publications
Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 May 16;
Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 07/01/2019
Board Certifications
Neonatal-Perinatal Medicine Pediatrics
Fellowship
Vanderbilt University Medical Center
Date Completed: 06/30/2019
Residency
University of Kansas School of Medicine
Date Completed: 06/30/2016
Medical School
University of Kansas
Date Completed: 05/18/2013
Contact Information
Pediatrics
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
PediatricsNeonatology700 Childrens DrColumbus, OH 43205 (map)
Learn more about Matthew J. Kielt
Contact Information
- Call us at:
- (614) 722-4530
- Fax us at:
- (614) 722-4541
- PediatricsNeonatology700 Childrens DrColumbus, OH 43205 (map)
Learn more about Matthew J. Kielt
Biography
Matthew J, Kielt, MD, is an attending neonatologist at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Kielt’s clinical interests include bronchopulmonary dysplasia (BPD) and neonatal pulmonary vascular disease. He practices in the Comprehensive Center for Bronchopulmonary Dysplasia. Dr. Kielt’s research interests focus on improving outcomes of infants with the most severe forms of BPD through the development of precision medicine strategies of neonatal care.
Biography
Matthew J, Kielt, MD, is an attending neonatologist at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Kielt’s clinical interests include bronchopulmonary dysplasia (BPD) and neonatal pulmonary vascular disease. He practices in the Comprehensive Center for Bronchopulmonary Dysplasia. Dr. Kielt’s research interests focus on improving outcomes of infants with the most severe forms of BPD through the development of precision medicine strategies of neonatal care.
Biography
Matthew J, Kielt, MD, is an attending neonatologist at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Kielt’s clinical interests include bronchopulmonary dysplasia (BPD) and neonatal pulmonary vascular disease. He practices in the Comprehensive Center for Bronchopulmonary Dysplasia. Dr. Kielt’s research interests focus on improving outcomes of infants with the most severe forms of BPD through the development of precision medicine strategies of neonatal care.
Matthew J, Kielt, MD, is an attending neonatologist at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Kielt’s clinical interests include bronchopulmonary dysplasia (BPD) and neonatal pulmonary vascular disease. He practices in the Comprehensive Center for Bronchopulmonary Dysplasia. Dr. Kielt’s research interests focus on improving outcomes of infants with the most severe forms of BPD through the development of precision medicine strategies of neonatal care.
Matthew J, Kielt, MD, is an attending neonatologist at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Kielt’s clinical interests include bronchopulmonary dysplasia (BPD) and neonatal pulmonary vascular disease. He practices in the Comprehensive Center for Bronchopulmonary Dysplasia.
Dr. Kielt’s research interests focus on improving outcomes of infants with the most severe forms of BPD through the development of precision medicine strategies of neonatal care.
Academic and Clinical Areas
Neonatology
Physician Team
Neonatology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Neonatology
Academic and Clinical Areas
Neonatology
Physician Team
Neonatology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Neonatology
Academic and Clinical Areas
Neonatology
Physician Team
Neonatology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Neonatology
Neonatology
Physician Team
Neonatology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Neonatology
- Neonatology
- Physician Team
- Neonatology Fellowship
- Faculty
- Primary Department
- Pediatrics
- Primary Section
- Neonatology
Research
Publications
Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 May 16;
Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
View More Publications
Research
Publications
Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 May 16;
Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
View More Publications
Research
Publications
Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 May 16;
Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
View More Publications
Publications
Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 May 16;
Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
View More Publications
Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 May 16;
Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children's Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
View More Publications
- Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2022 Dec 9;
- Kielt MJ, Lewis TR. Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?-Reply. JAMA Pediatr. 2022 Nov 7;
- Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, Nelin LD, Abman SH, Bronchopulmonary Dysplasia Collaborative.. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022 Aug 1;
- Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022 Jul; 8:
- Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM, Children’s Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children’s hospitals. Pediatr Pulmonol. 2022 May 16;
- Logan JW, Bapat R, Ryshen G, Bagwell G, Eisner M, Kielt M, Hanawalt M, Payne K, Alt-Coan A, Tatad M, Krendl D, Jebbia M, Reber KM, Halling C, Osman AA, Bonachea EM, Nelin LD, Fathi O. Use of a quality scorecard to enhance quality and safety in community hospital newborn nurseries. J Pediatr. 2022 Mar 28;
- Miller AN, Kielt MJ, El-Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022; 10: 1022743.
- Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Nelin LD, Shepherd EG, Reber KM, Fathi O. Perspectives on developing and sustaining a small baby program. Semin Perinatol. 2021 Nov 10; 151548.
- Kielt MJ, Logan JW, Backes CH, Conroy S, Reber KM, Shepherd EG, Nelin LD. Noninvasive Respiratory Severity Indices Predict Adverse Outcomes in Bronchopulmonary Dysplasia. J Pediatr. 2021 Nov 11;
- Kielt MJ, Murphy A, Smathers J, Bates M, Nelin LD, Shepherd EG. In-Hospital Respiratory Viral Infections for Patients with Established BPD in the SARS-CoV-2 Era. Pediatr Pulmonol. 2021 Oct 1;
- Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR, Children’s Hospitals Neonatal Consortium (CHNC) Severe BPD Focus Group.. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 Oct; 56: 3283-3292.
- McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M, BPD Collaborative.. Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr. 2021 Oct 26;
- Kielt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of late referrals for established bronchopulmonary dysplasia. J Perinatol. 2021 Aug; 41: 1972-1982.
- Cai Y, Yan L, Kielt MJ, Cogan JD, Hedges LK, Nunley B, West J, Austin ED, Hamid R. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5. Am J Respir Cell Mol Biol. 2021 Jan; 64: 140-143.
- Pavlek LR, Mueller C, Jebbia MR, Kielt MJ, Fathi O. Near-Infrared Spectroscopy in Extremely Preterm Infants. Front Pediatr. 2020; 8: 624113.
- Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019 Aug 6;
- Alliston D, Kielt MJ, Nehme G, Wittler R. Group Evaluations of Individual Faculty Hospitalists. Kans J Med. 2019 Aug; 12: 62-64.
- Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, Danhaive O. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension. Eur Respir J. 2019 May 31;
Education
Date of Appointment at Nationwide Children’s Hospital: 07/01/2019
Board Certifications
Neonatal-Perinatal Medicine Pediatrics
Fellowship
Vanderbilt University Medical Center
Date Completed: 06/30/2019
Residency
University of Kansas School of Medicine
Date Completed: 06/30/2016
Medical School
University of Kansas
Date Completed: 05/18/2013
Education
Date of Appointment at Nationwide Children’s Hospital: 07/01/2019
Board Certifications
Neonatal-Perinatal Medicine Pediatrics
Fellowship
Vanderbilt University Medical Center
Date Completed: 06/30/2019
Residency
University of Kansas School of Medicine
Date Completed: 06/30/2016
Medical School
University of Kansas
Date Completed: 05/18/2013
Education
Date of Appointment at Nationwide Children’s Hospital: 07/01/2019
Board Certifications
Neonatal-Perinatal Medicine Pediatrics
Fellowship
Vanderbilt University Medical Center
Date Completed: 06/30/2019
Residency
University of Kansas School of Medicine
Date Completed: 06/30/2016
Medical School
University of Kansas
Date Completed: 05/18/2013
Date of Appointment at Nationwide Children’s Hospital: 07/01/2019
Board Certifications
Neonatal-Perinatal Medicine Pediatrics
Fellowship
Vanderbilt University Medical Center
Date Completed: 06/30/2019
Residency
University of Kansas School of Medicine
Date Completed: 06/30/2016
Medical School
University of Kansas
Date Completed: 05/18/2013
Date of Appointment at Nationwide Children’s Hospital: 07/01/2019
Board Certifications
Neonatal-Perinatal Medicine Pediatrics
Fellowship
Vanderbilt University Medical Center
Date Completed: 06/30/2019
Residency
University of Kansas School of Medicine
Date Completed: 06/30/2016
Medical School
University of Kansas
Date Completed: 05/18/2013
- Neonatal-Perinatal Medicine
- Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
Call us at: (614) 722-4530
Fax us at: (614) 722-4541
Neonatology700 Childrens DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-4530
- Fax us at:
- (614) 722-4541
- Neonatology700 Childrens DrColumbus, OH 43205 (map)
